Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Fetal nasal bone in screening for trisomies 21, 18 and 13 and Turner syndrome at 11–13 weeks of gestation

26 Feb 2009

Abstract excerpt

OBJECTIVE: To investigate the performance of first-trimester screening for aneuploidies by including assessment of the fetal nasal bone in the combined test of maternal age, fetal nuchal translucency (NT) thickness, fetal heart rate (FHR) and serum free beta-human chorionic gonadotropin (beta-hCG) and pregnancy-associated plasma protein-A (PAPP-A). METHODS: Screening by the combined test was performed in...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Assisted Reproductive Technology and Twin Pregnancy
Share to Genomic variations and chromosomal abnormalities
Share to Prenatal Screening and Diagnostics

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 19248005
DOI: 10.1002/uog.6318

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Fetal nasal bone in screening for trisomies 21, 18 and 13 and Turner syndrome at 11–13 weeks of gestationPMID 19248005Read ↗

Absence of fetal nasal bone and aneuploidies at first‐trimester nuchal translucency screening in unselected pregnanciesSemantic proximity Read ↗

Maternal serum biochemistry at 11-13+6 weeks in relation to the presence or absence of the fetal nasal bone on ultrasonography in chromosomally abnormal fetuses: an updated analysis of integrated ultrasound and biochemical screeningSemantic proximity Read ↗

Likelihood ratio for trisomy 21 in fetuses with absent nasal bone at the 11–14‐week scanSemantic proximity Read ↗

The Association Between Fetal Nasal Bone Hypoplasia and AneuploidySemantic proximity Read ↗

Absent nasal bone in the prenatal detection of fetuses with trisomy 21 in a high-risk populationSemantic proximity Read ↗

Prenatal diagnosis and outcomes in 320 fetuses with nasal bone anomaliesSemantic proximity Read ↗

First‐trimester screening for trisomies 18 and 13, triploidy and Turner syndrome by detailed early anomaly scanSemantic proximity Read ↗

CMA-first, ES-on-demand for fetuses with absent/hypoplastic nasal bone: a real-world diagnostic pathway and outcomes in 362 fetusesSemantic proximity Read ↗

First trimester combined screening for fetal aneuploidies enhanced with additional ultrasound markers: an 8-year prospective study.Semantic proximity Read ↗

Nasal bone in first-trimester screening for trisomy 21Semantic proximity Read ↗

Maternal ethnic origin and fetal nasal bones at 11–14 weeks of gestationSemantic proximity Read ↗

Prenatal chromosomal microarray analysis in foetuses with isolated absent or hypoplastic nasal boneSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.